Dimitar Vuchev

465 total citations
14 papers, 384 citations indexed

About

Dimitar Vuchev is a scholar working on Organic Chemistry, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Dimitar Vuchev has authored 14 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 4 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Dimitar Vuchev's work include Synthesis and Biological Evaluation (7 papers), Synthesis and biological activity (6 papers) and Synthesis and Characterization of Heterocyclic Compounds (5 papers). Dimitar Vuchev is often cited by papers focused on Synthesis and Biological Evaluation (7 papers), Synthesis and biological activity (6 papers) and Synthesis and Characterization of Heterocyclic Compounds (5 papers). Dimitar Vuchev collaborates with scholars based in Bulgaria, United States and Italy. Dimitar Vuchev's co-authors include Anelia Ts. Mavrova, Jordan A. Tsenov, Pavletta Denkova, Nikolay Vassilev, Denitsa Yancheva, Jordan Genov, Enrico Brunetti, Francesca Tamarozzi, Miglena K. Georgieva and F. Fratev and has published in prestigious journals such as Molecules, RSC Advances and European Journal of Medicinal Chemistry.

In The Last Decade

Dimitar Vuchev

12 papers receiving 369 citations

Peers

Dimitar Vuchev
Micah Maetani United States
Alba L. Montoya United States
Judith K. Huggan United Kingdom
Brian Jones United States
Andrea Bistrović United Kingdom
Micah Maetani United States
Dimitar Vuchev
Citations per year, relative to Dimitar Vuchev Dimitar Vuchev (= 1×) peers Micah Maetani

Countries citing papers authored by Dimitar Vuchev

Since Specialization
Citations

This map shows the geographic impact of Dimitar Vuchev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitar Vuchev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitar Vuchev more than expected).

Fields of papers citing papers by Dimitar Vuchev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitar Vuchev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitar Vuchev. The network helps show where Dimitar Vuchev may publish in the future.

Co-authorship network of co-authors of Dimitar Vuchev

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitar Vuchev. A scholar is included among the top collaborators of Dimitar Vuchev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitar Vuchev. Dimitar Vuchev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Vuchev, Dimitar, et al.. (2024). Dirofilariasis of the scrotum: a clinical case from Bulgaria. Helminthologia. 61(4). 357–359.
3.
Vuchev, Dimitar, et al.. (2024). Human Infection with the Nematode Gongylonema sp.: A Case Report from Bulgaria. Iranian Journal of Parasitology. 19(3). 366–369. 1 indexed citations
4.
Mavrova, Anelia Ts., Dimitar Vuchev, Giada Bassi, et al.. (2023). Benzimidazoles Containing Piperazine Skeleton at C-2 Position as Promising Tubulin Modulators with Anthelmintic and Antineoplastic Activity. Pharmaceuticals. 16(11). 1518–1518. 3 indexed citations
5.
Georgiev, Nikolai I., Dimitar Vuchev, Georgi Momekov, et al.. (2023). Fused Triazinobenzimidazoles Bearing Heterocyclic Moiety: Synthesis, Structure Investigations, and In Silico and In Vitro Biological Activity. Molecules. 28(13). 5034–5034. 4 indexed citations
6.
Vuchev, Dimitar, et al.. (2023). Treatment of hepatic and pulmonary hydatidosis with albendazole and praziquantel. Helminthologia. 60(3). 221–226. 3 indexed citations
7.
Uzunova, Veselina, Anelia Ts. Mavrova, Dimitar Vuchev, et al.. (2021). 1H-benzimidazole-2-yl hydrazones as tubulin-targeting agents: Synthesis, structural characterization, anthelmintic activity and antiproliferative activity against MCF-7 breast carcinoma cells and molecular docking studies. Chemico-Biological Interactions. 345. 109540–109540. 33 indexed citations
8.
Georgieva, Miglena K., et al.. (2021). New 1H-benzimidazole-2-yl hydrazones with combined antiparasitic and antioxidant activity. RSC Advances. 11(63). 39848–39868. 25 indexed citations
9.
Dobrev, Hristo, et al.. (2015). Cutaneous Leishmaniasis – Dermoscopic Findings And Cryotherapy. Folia Medica. 57(1). 65–68. 5 indexed citations
10.
Genov, Jordan, et al.. (2011). Efficacy and Safety of PAIR for Cystic Echinococcosis: Experience on a Large Series of Patients from Bulgaria. American Journal of Tropical Medicine and Hygiene. 84(1). 48–51. 41 indexed citations
11.
Mavrova, Anelia Ts., et al.. (2010). Synthesis, antitrichinnellosis and antiprotozoal activity of some novel thieno[2,3-d]pyrimidin-4(3H)-ones containing benzimidazole ring. European Journal of Medicinal Chemistry. 45(12). 5856–5861. 67 indexed citations
13.
Mavrova, Anelia Ts., et al.. (2006). Antihelminthic activity of some newly synthesized 5(6)-(un)substituted-1H-benzimidazol-2-ylthioacetylpiperazine derivatives. European Journal of Medicinal Chemistry. 41(12). 1412–1420. 128 indexed citations
14.
Mavrova, Anelia Ts., et al.. (2005). Synthesis and antitrichinellosis activity of some 2-substituted-[1,3]thiazolo[3,2-a]benzimidazol-3(2H)-ones. Bioorganic & Medicinal Chemistry. 13(19). 5550–5559. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026